Mbxbio
4 known investors
MBX Biosciences develops precision endocrine peptide (PEP) therapies for patients with endocrine and metabolic disorders such as hypoparathyroidism. The clinical-stage biotech company focuses on creating peptide-based medicines for underserved patient markets.
BiotechHealthtech
Founders & leadership
SH
Steve HoerterChairman and Chief Executive Officer
Investors Β· 4
Frequently asked questions
- What does Mbxbio do?
- MBX Biosciences develops precision endocrine peptide (PEP) therapies for patients with endocrine and metabolic disorders such as hypoparathyroidism. The clinical-stage biotech company focuses on creating peptide-based medicines for underserved patient markets.
- Who are Mbxbio's investors?
- Mbxbio's investors include Frazier Life Sciences, IU Ventures, OrbiMed, New Enterprise Associates (NEA).